Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years

Improvements in PN were greater following nemolizumab treatment, despite continuation of topical corticosteroids in both groups.